Saturday, January 24, 2009


The biotech industry has found many friends within the Patrick administration and the state Legislature, securing a 10-year $1 billion investment package last session. On Wednesday, an industry-sponsored event at a Boston hotel will attract Lt. Gov Tim Murray, Mass Life Sciences Center President and CEO Susan Windham-Bannister, and Rep. Michael Rodrigues (D-Westport), in addition to executives from Cubist Pharmaceuticals, Wyeth, and Merck & Co. Mass. Biotech Council President Robert Coughlin offers opening remarks at the council's annual policy leadership luncheon, which is intended to "set the stage for the 2009 legislative sessions on Beacon Hill and Capitol Hill." The council will roll out a federal policy white paper outlining key issues that will affect the biotech and life sciences sectors in the 2009 Congressional session. Topics on the agenda include the future of health care and innovative medicines.

(Wednesday, 11 am, Parker House Hotel, 60 School St., Boston)

No comments: